open access

Vol 81, No 3 (2022)
Review article
Submitted: 2021-07-15
Accepted: 2021-08-04
Published online: 2021-08-24
Get Citation

Morphological and clinical picture of the morphea in the oral cavity

M. Pedowska1, M. Ptasiewicz1, J. Szumiło2, R. Chałas1
·
Pubmed: 34608983
·
Folia Morphol 2022;81(3):544-550.
Affiliations
  1. Department of Oral Medicine, Medical University of Lublin, Poland
  2. Department of Clinical Pathomorphology, Medical University of Lublin, Poland

open access

Vol 81, No 3 (2022)
REVIEW ARTICLES
Submitted: 2021-07-15
Accepted: 2021-08-04
Published online: 2021-08-24

Abstract

There are several types of morphea with different levels of connective tissue involvement and morphological manifestations.
In this mini review, it was pointed out the most important morphological and clinical aspects of localised scleroderma in the oral cavity. The case presented in this article supports the scientific information and is described with details. The morphea of mucous membrane which was clinically suspected, was proved by histopathological examination of the sample.
The unusual location of the local findings posed a diagnostic challenge. The case history should be significant due to the low number of studies. The special attention should be taken to match the clinical with pathomorphological picture in localised scleroderma diagnosis and treatment when the involvement of skin and oral mucosa is.

Abstract

There are several types of morphea with different levels of connective tissue involvement and morphological manifestations.
In this mini review, it was pointed out the most important morphological and clinical aspects of localised scleroderma in the oral cavity. The case presented in this article supports the scientific information and is described with details. The morphea of mucous membrane which was clinically suspected, was proved by histopathological examination of the sample.
The unusual location of the local findings posed a diagnostic challenge. The case history should be significant due to the low number of studies. The special attention should be taken to match the clinical with pathomorphological picture in localised scleroderma diagnosis and treatment when the involvement of skin and oral mucosa is.

Get Citation

Keywords

linear scleroderma, oral cavity, oral mucosa

About this article
Title

Morphological and clinical picture of the morphea in the oral cavity

Journal

Folia Morphologica

Issue

Vol 81, No 3 (2022)

Article type

Review article

Pages

544-550

Published online

2021-08-24

Page views

4578

Article views/downloads

1532

DOI

10.5603/FM.a2021.0083

Pubmed

34608983

Bibliographic record

Folia Morphol 2022;81(3):544-550.

Keywords

linear scleroderma
oral cavity
oral mucosa

Authors

M. Pedowska
M. Ptasiewicz
J. Szumiło
R. Chałas

References (24)
  1. Albuquerque JV, Andriolo BNg, Vasconcellos MRa, et al. Interventions for morphea. Cochrane Database Syst Rev. 2019; 7: CD005027.
  2. Asano Y, Fujimoto M, Ishikawa O, et al. Diagnostic criteria, severity classification and guidelines of localized scleroderma. J Dermatol. 2018; 45(7): 755–780.
  3. Bielsa Marsol I. Update on the classification and treatment of localized scleroderma. Actas Dermosifiliogr. 2013; 104(8): 654–666.
  4. Careta MF, Romiti R. Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol. 2015; 90(1): 62–73.
  5. Distler O, Cozzio A. Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy. Semin Immunopathol. 2016; 38(1): 87–95.
  6. Figueiroa Careta M, Romiti R. Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol. 2015; 90(1): 62–73.
  7. Khatri S, Torok KS, Mirizio E, et al. Autoantibodies in morphea: an update. Front Immunol. 2019; 10: 1487.
  8. Knobler R, Moinzadeh P, Hunzelmann N, et al. European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol. 2017; 31(9): 1401–1424.
  9. Kreuter A, Krieg T, Worm M, et al. German guidelines for the diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges. 2016; 14(2): 199–216.
  10. Kurzinski KL, Zigler CK, Torok KS. Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma. Br J Dermatol. 2019; 180(5): 1183–1189.
  11. Li S. Scleroderma in children and adolescents. Pediatr Clin North Am. 2018; 65(4): 757–781.
  12. Liu XS, Gao Y, Zheng LiWu, et al. New alternative therapy for orofacial localized scleroderma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 110(3): e15–e19.
  13. Machan A, Oumakhir S, Khalidi M, et al. Radiation-induced morphea: autoimmunity as a risk factor. Neth J Med. 2019; 77(1): 29–31.
  14. Mazori DR, Wright NA, Patel M, et al. Characteristics and treatment of adult-onset linear morphea: A retrospective cohort study of 61 patients at 3 tertiary care centers. J Am Acad Dermatol. 2016; 74(3): 577–579.
  15. Mertens JS, Seyger MMB, Thurlings RM, et al. Morphea and eosinophilic fasciitis: an update. Am J Clin Dermatol. 2017; 18(4): 491–512.
  16. Noakes R. Assessing the response of morphea and limited scleroderma to tranilast: a small prospective study comparing topical corticosteroids to a combination of topical corticosteroids and tranilast. Clin Cosmet Investig Dermatol. 2018; 11: 321–326.
  17. Ozlu E, Karadag AS, Akdeniz N, et al. Morphea secondary to interferon beta1b injection: a case and review of the literature. Dermatol Online J. 2019; 25(4).
  18. Rongioletti F, Ferreli C, Atzori L, et al. Scleroderma with an update about clinico-pathological correlation. G Ital Dermatol Venereol. 2018; 153(2): 208–215.
  19. Sartori-Valinotti JC, Tollefson MM, Reed AM. Updates on morphea: role of vascular injury and advances in treatment. Autoimmune Dis. 2013; 2013: 467808.
  20. Shalaby SM, Bosseila M, Fawzy MM, et al. Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study. Lasers Med Sci. 2016; 31(8): 1707–1715.
  21. Sommer A, Gambichler T, Bacharach-Buhles M, et al. Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients. J Am Acad Dermatol. 2006; 54(2): 227–233.
  22. Tang MM, Bornstein MM, Irla N, et al. Oral mucosal morphea: a new variant. Dermatology. 2012; 224(3): 215–220.
  23. Tratenberg M, Gutwein F, Rao V, et al. Localized scleroderma: a clinical review. Curr Rheumatol Rev. 2017; 13(2): 86–92.
  24. Vigneron C, Bauer N, Waisse W, et al. Morphée du sein radio-induite : une complication méconnue. Cancer/Radiothér. 2014; 18(1): 64–67.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.: +48 58 320 94 94, faks: +48 58 320 94 60, e-mail: viamedica@viamedica.pl